BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dreismann AK, McClements ME, Barnard AR, Orhan E, Hughes JP, Lachmann PJ, MacLaren RE. Functional expression of complement factor I following AAV-mediated gene delivery in the retina of mice and human cells. Gene Ther 2021;28:265-76. [PMID: 33750925 DOI: 10.1038/s41434-021-00239-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Ahmad A, Mandwie M, Dreismann AK, Smyth CM, Doyle H, Malik TH, Pickering MC, Lachmann PJ, Alexander IE, Logan GJ. Adeno-Associated Virus Vector Gene Delivery Elevates Factor I Levels and Downregulates the Complement Alternative Pathway In Vivo. Hum Gene Ther 2021. [PMID: 34238030 DOI: 10.1089/hum.2021.022] [Reference Citation Analysis]
2 Kamala O, Malik TH, Hallam TM, Cox TE, Yang Y, Vyas F, Luli S, Connelly C, Gibson B, Smith-Jackson K, Denton H, Pappworth IY, Huang L, Kavanagh D, Pickering MC, Marchbank KJ. Homodimeric Minimal Factor H: In Vivo Tracking and Extended Dosing Studies in Factor H Deficient Mice. Front Immunol 2021;12:752916. [PMID: 34956184 DOI: 10.3389/fimmu.2021.752916] [Reference Citation Analysis]
3 Clare AJ, Liu J, Copland DA, Theodoropoulou S, Dick AD. Unravelling the therapeutic potential of IL-33 for atrophic AMD. Eye (Lond) 2021. [PMID: 34531552 DOI: 10.1038/s41433-021-01725-5] [Reference Citation Analysis]
4 Yang B, Li G, Liu J, Li X, Zhang S, Sun F, Liu W. Nanotechnology for Age-Related Macular Degeneration. Pharmaceutics 2021;13:2035. [PMID: 34959316 DOI: 10.3390/pharmaceutics13122035] [Reference Citation Analysis]
5 Khanani AM, Thomas MJ, Aziz AA, Weng CY, Danzig CJ, Yiu G, Kiss S, Waheed NK, Kaiser PK. Review of gene therapies for age-related macular degeneration. Eye (Lond) 2022. [PMID: 35017696 DOI: 10.1038/s41433-021-01842-1] [Reference Citation Analysis]